We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$88.3B
AUM Growth
-$9.28B
Cap. Flow
-$11.2B
Cap. Flow %
-12.67%
Top 10 Hldgs %
21.92%
Holding
8,036
New
459
Increased
2,809
Reduced
4,029
Closed
382

Sector Composition

Rank Sector Weight
1 Healthcare 5.8%
2 Technology 4.73%
3 Financials 4.42%
4 Communication Services 3.81%
5 Real Estate 3.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMQ
7201
Trilogy Metals
TMQ
$541M
$3K ﹤0.01%
2,690
-16
-0.6% -$22
TPST icon
7202
Tempest Therapeutics
TPST
$13.7M
0
VCYT icon
7203
Veracyte
VCYT
$3.7B
$3K ﹤0.01%
196
+116
+145% +$1.85K
VICR icon
7204
CALL
Vicor
VICR
$9.56B
$3K ﹤0.01%
+300
New +$3.36K
ENFY
7205
PUT
DELISTED
Enlightify Inc
ENFY
$3K ﹤0.01%
+108
New +$4.18K
TVRD
7206
Tvardi Therapeutics
TVRD
$19.7M
$3K ﹤0.01%
+4
New +$2.37K
SPLP
7207
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
$3K ﹤0.01%
167
-466
-74% -$7.73K
BIOL
7208
DELISTED
Biolase, Inc.
BIOL
0
FRTX
7209
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$3K ﹤0.01%
1
INDT
7210
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$3K ﹤0.01%
104
+2
+2% +$62
ZNH
7211
DELISTED
China Southern Airlines Company Limited
ZNH
$3K ﹤0.01%
131
-7,085
-98% -$124K
SWIR
7212
DELISTED
Sierra Wireless
SWIR
$3K ﹤0.01%
147
+47
+47% +$1.03K
ABMD
7213
CALL
DELISTED
Abiomed Inc
ABMD
$3K ﹤0.01%
100
-600
-86% -$16.6K
SHI
7214
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
$3K ﹤0.01%
+136
New +$3.86K
MBII
7215
DELISTED
Marrone Bio Innovations, Inc.
MBII
$3K ﹤0.01%
217
+68
+46% +$1.07K
FOE
7216
PUT
DELISTED
Ferro Corporation
FOE
$3K ﹤0.01%
+200
New +$2.65K
MYC
7217
DELISTED
Blackrock Muni Yield California Fund, Inc.
MYC
$3K ﹤0.01%
236
-31,467
-99% -$455K
DRNA
7218
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3K ﹤0.01%
+96
New +$3.57K
NWHM
7219
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$3K ﹤0.01%
+245
New +$3.38K
CRCM
7220
DELISTED
CARE.COM, INC.
CRCM
$3K ﹤0.01%
+179
New +$3.9K
LOR
7221
DELISTED
Lazard World Dividend & Income Fund, Inc.
LOR
$3K ﹤0.01%
203
-7,648
-97% -$107K
MTB.WS
7222
DELISTED
M&T Bank Corporation
MTB.WS
$3K ﹤0.01%
66
STI.WS.B
7223
DELISTED
Suntrust Banks Inc
STI.WS.B
$3K ﹤0.01%
520
+350
+206% +$1.95K
BBG
7224
CALL
DELISTED
Bill Barrett Corp
BBG
$3K ﹤0.01%
100
-11,100
-99% -$284K
EXA
7225
DELISTED
EXA Corporation
EXA
$3K ﹤0.01%
200
-100
-33% -$1.42K

Similar funds

Barclays's Q1 2014 Portfolio in Review

As of Q1 2014, Barclays held 8,036 positions worth $88.3B, down 9.5% from $97.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $11.2B in Q1 2014, closing 382 positions and reducing 4,029 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $136M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.8% of assets, up from 5.2% a quarter earlier, followed by Technology and Financials.

Against the trend, Barclays opened a new position in LIN MEDIA LLC CLASS A COM worth $23.4M.

  • Barclays's largest Q1 2014 buy was LIN MEDIA LLC CLASS A COM: 898,200 shares worth $23.4M.
  • Barclays added most to State Street SPDR S&P Retail ETF in Q1 2014, an estimated $391M increase.
  • Barclays's biggest Q1 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.08B.
  • Barclays fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $136M.
  • Barclays's ten largest holdings make up 22% of its $88.3B portfolio in Q1 2014.
  • Barclays opened 459 new positions and closed 382 in Q1 2014.
  • Barclays's portfolio value fell 9.5% quarter-over-quarter to $88.3B.

Based on Barclays's 13F filing for Q1 2014, filed 15 May 2014.